A convoluted, confusing, and opaque system for pricing drugs has evolved that distorts the market and often limits patient access to the drugs they need to survive. In this episode, three experts explain how the system works—or doesn’t’—and the consequences of a dysfunctional pricing system.
Guests:
- Dan Durham, Senior Health Policy Advisor, Biotechnology Innovation Organization
- Anna Hyde, Vice President, Advocacy and Access, Arthritis Foundation
- Dr. Vinay Rathi, Resident Physician, Otolaryngology, Massachusetts Eye and Ear and Mass General Brigham
